GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Li Kang Biomedical Co Ltd (ROCO:6242) » Definitions » Total Equity

Li Kang Biomedical Co (ROCO:6242) Total Equity : NT$829.8 Mil (As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Li Kang Biomedical Co Total Equity?

Li Kang Biomedical Co's total equity for the quarter that ended in Sep. 2024 was NT$829.8 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Li Kang Biomedical Co Total Equity Historical Data

The historical data trend for Li Kang Biomedical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Li Kang Biomedical Co Total Equity Chart

Li Kang Biomedical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 483.44 508.30 492.00 570.14 630.03

Li Kang Biomedical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 602.21 630.03 869.28 811.16 829.77

Li Kang Biomedical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Li Kang Biomedical Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=827.005-196.973
=630.0

Li Kang Biomedical Co's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=993.434-163.661
=829.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Li Kang Biomedical Co Total Equity Related Terms

Thank you for viewing the detailed overview of Li Kang Biomedical Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Li Kang Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
No.29, Huangong Road, Yongkang District, Taipei City, TWN, 71041
Li Kang Biomedical Co Ltd is a Taiwan based company engages in tourism factory businesses, telemarketing, as well as the manufacturing and sales of cosmetics and hygienic drinks.

Li Kang Biomedical Co Headlines

No Headlines